• All Topics
  • Health Technology Assessment (HTA)
  • Antimicrobial Resistance (AMR)
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real-World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme
  • IRA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Health Technology Assessment…
  • Israel

NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

andrew-butler-aUu8tZFNgfM-unsplash
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Gene therapies

Are Recommendations for HTA of Gene Therapies Being Achieved?

cover 3
Read more
  • Chronic Diseases
  • Value, Affordability, and…
  • Dermatology

The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society

jakob-braun-HfOOKAPsE28-unsplash
Read more
  • Digital Health
  • Economics of Innovation
  • Mental Health

Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment

image option 1
Read more
  • Precision Medicine
  • Economics of Innovation

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

NGS report_AdobeStock_406823942_portrait
Read more
  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Roche AMR diangostics_national-cancer-institute-2fyeLhUeYpg-unsplash_portrait
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Pricing and Reimbursement

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

RWE_clay-banks-b5S4FrJb7yQ-unsplash_portrait
Read more
  • Value-Based Pricing
  • Economics of Innovation
  • Pricing and Reimbursement

Delivering the Triple Win: A Value-Based Approach to Pricing

Triple_Win_AdobeStock_249059909_portrait_v2
Read more
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real-World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • IRA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 2nd January 2020

OHE at HESG Winter 2020

Meet some of the OHE team at the Health Economists’ Study Group (HESG) Winter 2020 meeting in Newcastle, 6-8 January 2020. Meet some of the OHE team at the Health Economists’ Study Group (HESG) Winter 2020 Meeting in Newcastle, 6-8…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

Meet some of the OHE team at the Health Economists’ Study Group (HESG) Winter 2020 meeting in Newcastle, 6-8 January 2020.

Meet some of the OHE team at the Health Economists’ Study Group (HESG) Winter 2020 Meeting in Newcastle, 6-8 January 2020. The Meeting will be hosted by Newcastle University.

Apostolos Davillas, Mireia Jofre-Bonet, David Mott, Chris Sampson, Bernarda Zamora, and Kyann Zhang will be attending the conference and contributing to the programme in various capacities.

 

OHE work to be discussed:

 

A latent class approach to inequity in health using biomarker data

Tuesday, 7 January, 15:30 – 16:30, Locomotion 1

Authors: Apostolos Davillas, Vincenzo Carrieri and Andrew M. Jones

Summary: An empirical approach was developed to analyse, measure and decompose Inequality of Opportunity (IOp) in health, based on a latent class model. This aims to address the limitations that affect earlier work in this area concerning the definition of types – such as partial observability, the ad hoc selection of circumstances, the curse of dimensionality and unobserved type-specific heterogeneity – that may lead to either upwardly or downwardly biased estimates of IOp. The latent class approach was applied to quantify IOp in allostatic load, a composite measure of the biomarker data. Using data from Understanding Society (UKHLS), it was found that a latent class model with three unobserved types best fits the data and that these types differ in terms of their observed circumstances. Decomposition analysis shows that about two-thirds of the total inequality in allostatic load can be attributed to the direct and indirect contribution of circumstances.

Chair: Nicolas Silva. Discussant: Padraig Dixon.

 

Uncertainty in patient trade-offs: issues in the reporting of marginal rates of substitution in discrete choice experiments

Wednesday, 8 January, 10:30 – 11:25, Northumbrian

Author: David Mott, Nour Chami and Tommi Tervonen

Summary: The primary objective of this paper was to review recently published discrete choice experiment (DCE) studies that elicit patient preferences in relation to the reporting of marginal rates of substitution (MRS). A further objective was to explore the accuracy of using other reported information to estimate the uncertainty of MRS when it is not reported.

Chair: Tara Homer. Discussant: Katherine Carr.

 

Risk calculation engines, cost-effectiveness analysis, and Microsoft Excel: lessons from an intractable model

Wednesday, 8 January, 11:45 – 12:45, Rocket

Author: Chris Sampson

Summary: Decision analytic cost-effectiveness models are increasingly complex. One contemporary demonstration of this is the potential to integrate risk calculation engines, which can be used to dynamically determine parameters within a model. Microsoft Excel is one of the most commonly used software packages for the development of cost-effectiveness models, but it has recently faced criticism due to its supposed limitations. The purposes of this paper are twofold – first, to provide guidance on the incorporation of risk calculation engines into cost-effectiveness models and, second, to outline some of the practical limitations of Excel in this context

Chair: Helen Dakin. Discussant: Ed Wilson.

 

OHE team members will be chairing and discussing others’ papers at the following sessions:

 

Monday 6 January

An essay on the measurement of total health inequalities at the individual level

15:30 – 16:30, Locomotion 1

Author: Nicolas Silva-Illanes

Chair: Bernarda Zamora. Discussant: Morgan Beeson.

 

Tuesday 7 January

Emergency readmissions as a quality measure: The impact of definition on the output and productivity of the English NHS

09:30 – 10:25, Locomotion 1

Author: Idaira Rodriguez Santana

Chair: Helen Mason. Discussant: Bernarda Zamora.

The Impact of Hosting a Major International Sporting Event on Health and Health-related Behaviours

09:30 – 10:25, Locomotion 2

Author: Sean Gavan

Chair: Adam Wagner. Discussant: Mireia Jofre-Bonet.

Does public adult social care expenditure improve care-related quality of life in England?

09:30 – 10:25, Rocket

Author: Francesco Longo

Chair: Stavros Petrou. Discussant: Chris Sampson.

The role of GPs risk attitudes and personalities in the uptake of procedural or specialist services in rural areas

10:30 – 11:25, Locomotion 2

Author: Xuemin Zhu

Chair: Ranya Alakraa. Discussant: Kyann Zhang.

General practice employment models and job satisfaction: Evidence from the GP Worklife Survey in England 2001-2017

13:45 – 14:45, Locomotion 1

Author: Jon Gibson

Chair: Mireia Jofre-Bonet. Discussant: Ashleigh Kernohan.

Estimating the economic impact of digital health interventions using routinely collected data and quasi-experimental methods: a case study in primary care patient safety

15:30 – 16:30, Rocket

Author: Leonie Brinkmann

Chair: Chris Sampson. Discussant: Martin Downes.

 

Wednesday 8 January

Empirical comparison of capability instruments in mental health research: OxCAP-MH vs. ICECAP-A in schizophrenic patients with depression

09:30 – 10:25, Northumbrian 

Author: Timea Helter

Chair: Xuemin Zhu. Discussant: David Mott.

  • Research
  • Measuring and Valuing Outcomes
  • Presentations

Related News

  • News
  • March 2020

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.

Read more
  • News
  • March 2020

Price Transparency: Good or Bad? What Does Literature and Theory Tell Us?

Read more
  • News
  • January 2020

Funding Challenges in the Malaysian Health Care System

Read more
  • News
  • December 2019

OHE Presents at Global AMR R&D Hub Board of Members Meeting in Paris

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!